The DOI matches its Crossref record.
Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Abstract
This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic patients are at high risk of cardiovascular events, particularly of coronary heart disease by about 3-fold [67,68].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [67]
In the citing paper
“T2DM is associated with a two-fold higher risk of CAD and ischaemic stroke”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
In the citing paper
“and a two-to four-fold higher CAD-and stroke-related mortality.139 -141”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
Citations
Cited by
Sorted by citations
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
“Three reasons probably account for similar results when continuous or categorical formulations are used: (1) a large enough number of categories has been used to adequately describe the clinical data; (2) coronary prediction equations have limitations in their precision and accuracy; and (3) in the final steps of the…”
ResultSelf-citationHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Self-citationGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Diabetes and cardiovascular disease
Howard, B. V., & Magee, M. F. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0046-8 · Cited by 1,386
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,222
“3 mmol/L]) compared with those without, with an even greater impact of diabetes mellitus on cardiovascular morbidity and mortality for women than for men.(10) The increased risk for ASCVD in diabetes mellitus could not be fully accounted for by associated traditional cardiovascular risk factors, and the presence of di…”
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Impact of Diabetes on Cardiac Structure and Function
Devereux, R. B., Roman, M. J., Paranicas, M., O’Grady, M. J., Lee, E. T., Welty, T. K., Fabsitz, R. R., Robbins, D. C., Rhoades, E. R., & Howard, B. V. (2000) · Circulation · doi:10.1161/01.cir.101.19.2271 · Cited by 943
“The specific objectives were to determine whether (1) non–insulin-dependent DM is associated with LV hypertrophy and dysfunction in a population-based sample of middle-aged to elderly adults, (2) observed associations are independent of major correlates of LV hypertrophy (body size, BP, sex, and age), and (3) DM is as…”
BackgroundDiabetes and atherosclerosis: An epidemiologic view
Pyörälà, K., Laakso, M., & Uusitupa, M. I. J. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030206 · Cited by 912
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Booth, G. L., Kapral, M. K., Fung, K., & Tu, J. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68967-8 · Cited by 782
Serruys, P. W. J. C. (2002) · JAMA · doi:10.1001/jama.287.24.3215 · Cited by 716
“The subgroup analyses showing benefit of therapy in multivessel disease and in diabetic patients are not surprising because these factors are known to increase CHD risk.(4,16,17) In these subpopulations, fluvastatin treatment appears to stabilize CHD risk, with an incidence of cardiac events in patients taking fluvast…”
ResultSeferović, P. M., Petrie, M. C., Filippatos, G. S., Anker, S. D., Rosano, G., Bauersachs, J., Paulus, W. J., Komajda, M., Cosentino, F., de Boer, R. A., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1170 · Cited by 708
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study
Kannel, W. B. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90224-8 · Cited by 664
Self-citationTrends in cardiovascular complications of diabetes
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.292.20.2495 · Cited by 626
Grundy, S. M., Balady, G. J., Criqui, M. H., Fletcher, G., Greenland, P., Hiratzka, L. F., Houston-Miller, N., Kris-Etherton, P., Krumholz, H. M., LaRosa, J., et al. (1998) · Circulation · doi:10.1161/01.cir.97.18.1876 · Cited by 609
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
“Therefore, it is not surprising that the risk of coronary heart disease (CHD), cerebrovascular disease, and peripheral vascular disease is severalfold increased in type 2 diabetes (2) and that CVDs, as a group, represent the leading cause of death in type 2 diabetes (3).”
BackgroundThe effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus
Borch‐Johnsen, K., Andersen, P. K., & Deckert, T. (1985) · Diabetologia · doi:10.1007/bf00281993 · Cited by 601
“The substantially increased mortality from arterial diseases in subjects with diabetes mellitus has long been recognized [1, 2].”
BackgroundMetformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567
“Diabetic patients are at high risk of cardiovascular events, particularly of coronary heart disease by about 3-fold [67,68].”
BackgroundMortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus
Panzram, G. (1987) · Diabetologia · doi:10.1007/bf00274216 · Cited by 538
(1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80683-3 · Cited by 538
Stone, P. H., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., Turi, Z. G., Strausś, H. W., Willerson, J. T., ROBERTSON, T. L., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90053-3 · Cited by 514
Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity
Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K., Harrison, D. G., & Tsao, P. S. (2001) · Circulation Research · doi:10.1161/hh1201.092042 · Cited by 484
“Discussion The salient findings of the present study are as follows: (1) 92-kDa gelatinolytic activity (MMP-9) in aortic homogenates and plasma from rat models of diabetes is significantly increased compared with that from control rats; (2) chronic culture in HG conditions enhances MMP-9 expression and activity in end…”
Affner, S. T. M. H., Ehto, S. E. L., Önnemaa, T. A. R., Yörälä, K. A. P., & Aakso, M. A. L. (1998) · Cited by 480
Haffner, S. M., Mykkänen, L., Festa, A., Burke, J. P., & Stern, M. P. (2000) · Circulation · doi:10.1161/01.cir.101.9.975 · Cited by 455
The Primary Prevention of Myocardial Infarction
Manson, J. E., Tosteson, H., Ridker, P. M., Satterfield, S., Hebert, P., O'Connor, G. T., Buring, J. E., & Hennekens, C. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262107 · Cited by 508
Haffner, S. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2661 · Cited by 441
“Among patients with NFG, the risk reduction in the simvastatin group was statistically significant for (1) major coronary events, odds ratio (OR), −32% (95% CI, −41% to −21%; P,.”
BackgroundMethodInfluentialJarrett, R. J., McCartney, P., & KEEN, H. (1982) · Diabetologia · doi:10.1007/bf00254833 · Cited by 436
“In the Framingham prospective study the risk indices of age, LDL cholesterol, low HDL cholesterol, blood pressure and cigarette smoking were common to diabetics and non-diabetics alike, using both atherosclerotic and hypertensive cardiovascular disease (morbidity and mortality) as end points [16].”
BackgroundLaing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 427
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations
Grundy, S. M., Pasternak, R. C., Greenland, P., Smith, S. C., & Fuster, V. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00387-3 · Cited by 403
Franco, O. H., Steyerberg, E. W., Hu, F. B., Mackenbach, J., & Nusselder, W. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1145 · Cited by 400
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
Brea, Á., Mosquera, D., Martin‐Solana, E., Arizti, A., Cordero, J. L., & Ros, E. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160613.57985.18 · Cited by 384
Sudden death: Lessons from subsets in population studies
Kannel, W. B., & Schatzkin, A. G. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80545-3 · Cited by 381
Self-citationIs diabetes a coronary risk equivalent? Systematic review and meta‐analysis
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., & IDRIS, I. R. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02640.x · Cited by 377
Erdmann, E., Dormandy, J., Charbonnel, B. H., Massi‐Benedetti, M., Moules, I. K., & Skene, A. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.12.048 · Cited by 377
Risk factors that attenuate the female coronary disease advantage
Kannel, W. B. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430010063008 · Cited by 381
Self-citationCoronary atherosclerosis in diabetes mellitus
Goraya, T., Leibson, C. L., Palumbo, P. J., Weston, S. A., Killian, J. M., Pfeifer, E. A., Jacobsen, S. J., Frye, R. L., & Roger, V. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02065-x · Cited by 353
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
Hayat, S. A., Patel, B., Khattar, R. S., & Malik, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 353
Diabetic foot ulcers: prevention, diagnosis and classification.
Armstrong, D. G., & Lavery, L. A. (1998) · PubMed · Cited by 341
Coronary Artery Disease: From Mechanism to Clinical Practice
Shao, C., Wang, J., Tian, J., & Tang, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2517-9_1 · Cited by 368
The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality
Fox, C. S., SULLIVAN, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.704 · Cited by 318
“T ype 2 diabetes confers a two- to threefold increase in the risk of cardiovascular disease (CVD) (1).”
BackgroundCause-specific mortality in a population-based study of diabetes.
Moss, S. E., Klein, R., & Klein, R. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.9.1158 · Cited by 315
Prevention Conference VI: Diabetes and Cardiovascular Disease
Howard, B. V., Rodríguez, B. L., Bennett, P. H., Harris, M. I., Hamman, R. F., Kuller, L. H., Pearson, T. A., & Wylie‐Rosett, J. (2002) · Circulation · doi:10.1161/01.cir.0000013953.41667.09 · Cited by 307
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00076.x · Cited by 303
Ghouri, N., Preiss, D., & Sattar, N. A. (2010) · Hepatology · doi:10.1002/hep.23789 · Cited by 302
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 345
Diabetes and atherosclerosis: is there a role for hyperglycemia?
Chait, A., & Bornfeldt, K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800059-jlr200 · Cited by 298
A Meta-analysis Comparing the Effect of Thiazolidinediones on Cardiovascular Risk Factors
Chiquette, E., Ramı́rez, G., & DeFronzo, R. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2097 · Cited by 291
“syndrome, with or without type 2 diabetes, are at increased risk of CVD.(40-43)”
Uusitupa, M. I. J., NISKANEN, L. K., Siitonen, O., Voutilainen, E., & Pyörälà, K. (1990) · Circulation · doi:10.1161/01.cir.82.1.27 · Cited by 289
“Prevalence of claudication at baselinet 6/70 (9) 4/62 (7) NS 2/63 (3) 1/82 (1) NS”
THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
King, G. L., & Brownlee, M. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70324-8 · Cited by 289
Paone, S., Baxter, A. A., Hulett, M. D., & Poon, I. K. H. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2983-9 · Cited by 281
Insulin resistance, inflammation, and the prediabetic state
Haffner, S. M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00612-x · Cited by 270
Sastre, A. A., Vernooij, R. W. M., Harmand, M. G., & Martínez, G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003804.pub2 · Cited by 283
Primary Prevention of Coronary Heart Disease
Grundy, S. M. (1999) · Circulation · doi:10.1161/01.cir.100.9.988 · Cited by 266
Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study
O’Donnell, C. J., & Elosúa, R. (2008) · Revista Española de Cardiología · doi:10.1157/13116658 · Cited by 282
Cardiovascular Risk Factors. Insights From Framingham Heart Study
O’Donnell, C. J., & Elosúa, R. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60118-8 · Cited by 272
“56 Moreover, diabetes is also associated with a higher probability of presenting with hypertrigliceridemia, low HDL-C, high blood pressure, and obesity, which usually precede the onset of diabetes.”
BackgroundPrevalence of small vessel and large vessel disease in diabetic patients from 14 centres
Diabetes Drafting Group (1985) · Diabetologia · doi:10.1007/bf00290267 · Cited by 264
Marre, M., Leblanc, H., Suarez, L., et al. (1987) · BMJ · doi:10.1136/bmj.294.6585.1448 · Cited by 261
DNA damage and repair in type 2 diabetes mellitus
Błasiak, J., Arabski, M., Krupa, R., Woźniak, K., Zadrożny, M., Kasznicki, J., Żurawska-Kliś, M., & Drzewoski, J. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.011 · Cited by 258
Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among Men
Kenchaiah, S., Sesso, H. D., & Gaziano, J. M. (2008) · Circulation · doi:10.1161/circulationaha.108.807289 · Cited by 252
Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
Scognamiglio, R., Negut, C., Ramondo, A., Tiengo, A., & Avogaro, A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.008 · Cited by 249
Fonseca, V. A., Rosenstock, J., Wang, A. C., Truitt, K. E., & Jones, M. R. (2008) · Diabetes Care · doi:10.2337/dc08-0283 · Cited by 245
“Although the impact of hyperglycemia on macrovascular complications is unknown, individuals with type 2 diabetes have a two- to fourfold higher risk for initial coronary events, and more importantly, those developing coronary heart disease have a relatively poor prognosis for recurrent coronary heart disease events an…”
BackgroundImpact of Diabetes on Long-Term Survival After Acute Myocardial Infarction
Mukamal, K. J., Nesto, R. W., Cohen, M. C., Muller, J. E., Maclure, M., Sherwood, J. B., & Mittleman, M. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1422 · Cited by 244
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes
Howard, B. V. (2008) · JAMA · doi:10.1001/jama.299.14.1678 · Cited by 238
Association of Ocular Disease and Mortality in a Diabetic Population
Klein, R. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.11.1487 · Cited by 225
Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians
Lotufo, P. A., Gaziano, J. M., Chae, C. U., Ajani, U. A., Moreno-John, G., Buring, J. E., & Manson, J. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.242 · Cited by 216
“Several epidemiologic studies indicate that men with diabetes mellitus are 2 to 3 times more likely to die from CHD than those without diabetes,(2-5) and women with diabetes face an even higher risk.(6,7) Diabetes increases the case-fatality rate of myocardial infarction (MI) events,(8-10) and prehospital mortality fr…”
BackgroundThe risk of venous thromboembolism is markedly elevated in patients with diabetes
Petrauskienė, V., Falk, M., Waernbaum, I., Norberg, M., & Eriksson, J. W. (2005) · Diabetologia · doi:10.1007/s00125-005-1715-5 · Cited by 218
“The Framingham Study found no relationship between glucose levels and the occurrence of VTE [2].”
BackgroundInfluence of diabetes mellitus on heart failure risk and outcome
Bauters, C., Lamblin, N., Fadden, E. P. M., BELLE, E. V., Millaire, A., & de Groote, P. (2003) · Cardiovascular Diabetology · doi:10.1186/1475-2840-2-1 · Cited by 214
“In the Framingham cohort, diabetic men and women had higher blood pressures and were more obese than non-diabetics; diabetic women had, in addition, higher LDL-cholesterol values; HDL-cholesterol values were consistently lower in those with DM than in those without DM in both sexes [26].”
The epidemiology and natural history of NIDDM—lessons from the South Pacific
Zimmet, P., Dowse, G., Finch, C., Serjeantson, S., & King, H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060203 · Cited by 214
The Association of Glycemia and Cause-Specific Mortality in a Diabetic Population
Moss, S. E. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420210113013 · Cited by 215
Cardiovascular disease in diabetes, beyond glucose
Eckel, R. H., Bornfeldt, K., & Goldberg, I. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.001 · Cited by 235
Hempel, A., Maasch, C., Heintze, U., Lindschau, C., Dietz, R., Luft, F. C., & Haller, H. G. (1997) · Circulation Research · doi:10.1161/01.res.81.3.363 · Cited by 211
Hyperlipidemia and Diabetes Mellitus
O’Brien, T., Nguyen, T. T., & Zimmerman, B. R. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.10.969 · Cited by 203
Pistachio nuts: composition and potential health benefits
Dreher, M. L. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00467.x · Cited by 201
Pasanen, K., Parkkari, J. P., Pasanen, M. E., Hiilloskorpi, H., Mäkinen, T., Järvinen, M., & Kannus, P. (2008) · British Journal of Sports Medicine · doi:10.1136/bmj.a295 · Cited by 212
DNA Damage in Diabetes: Correlation with a Clinical Marker
Collins, A. R., Rašlová, K., Somorovská, M., Petrovská, H., Ondrusova, A., Vohnout, B., Fábry, R., & Dušinská, M. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00053-7 · Cited by 189
Thomsen, T. F., McGee, D., Davidsen, M., & Jørgensen, T. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.4.817 · Cited by 183
Self-citationCoronary heart disease risk equivalence in diabetes depends on concomitant risk factors
Howard, B. V., Best, L. G., Galloway, J. M., Howard, W. J., Jones, K., Lee, E. T., Ratner, R. E., Resnick, H. E., & Devereux, R. B. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1299 · Cited by 180
“The cumulative effect of risk factors in diabetic patients was similar to that shown in analyses from the Atherosclerosis Risk in Communities (27) and Framingham ( 28 ) studies, and this heterogeneity of risk in diabetic individuals has long been described in publications focusing on individual risk factors in diabeti…”
BackgroundResultKocsis, T., Molnár, B., Németh, D. I., Hegyi, P., Szakács, Z., Bálint, A., Garami, A., Soós, A., Márta, K., & Solymár, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-68440-1 · Cited by 194
Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006
Smith, A. D., Bradley, D. J., Smith, V. A., Blaze, M., Behrens, R. H., Chiodini, P. L., & Whitty, C. W. M. (2008) · BMJ · doi:10.1136/bmj.a120 · Cited by 178
Human cerebral neuropathology of Type 2 diabetes mellitus
Nelson, P. T., Smith, C. D., Abner, E. L., Schmitt, F. A., Scheff, S. W., Davis, G. J., Keller, J. N., Jicha, G. A., Davis, D. G., Wang, W., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.005 · Cited by 178
Intensive glycemic control and cardiovascular disease: an update
Brown, A., Reynolds, L. R., & Bruemmer, D. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.35 · Cited by 172
“Epidemiological studies have demonstrated that diabetes is an independent risk factor for cardiovascular disease and is associated with a 2–4-fold increased risk of coronary heart disease”
BackgroundMicrovascular complications of diabetes
He, Z., & King, G. L. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2003.12.003 · Cited by 169
Taniyama, Y., Morishita, R., Hiraoka, K., et al. (2001) · Circulation · doi:10.1161/hc4401.098470 · Cited by 168
Sun, B., Luo, Z., & Zhou, J. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01200-7 · Cited by 168
Hironori Nakagami, A., Morishita, R., Yamamoto, K., Yoshimura, S.-I., Taniyama, Y., Aoki, M., Matsubara, H., Kim, S., Kaneda, Y., & Ogihara, T. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1472 · Cited by 163
Multivariate analysis of the insulin resistance syndrome in women.
Edwards, K. L., Austin, M. A., Newman, B. M., Mayer, E. J., Krauss, R. M., & Selby, J. V. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.1940 · Cited by 159
Merat, S., Casanada, F., Sutphin, M. S., Palinski, W., & Reaven, P. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1223 · Cited by 158
Becker‐Commissaris, A. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00197-0 · Cited by 163
Diabetes and Cardiovascular Disease
Resnick, H. E., & Howard, B. V. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103904 · Cited by 165
“The Framingham study [ 26 ] first reported that women and men with diabetes have virtually equal CHD incidence rates.”
BackgroundSudden Death, Impaired Glucose Tolerance, and Diabetes in Japanese American Men
Curb, J. D., Rodríguez, B. L., Burchfiel, C. M., Abbott, R. D., Chiu, D., & Yano, K. (1995) · Circulation · doi:10.1161/01.cir.91.10.2591 · Cited by 156
Uribarri, J., Stirban, A. O., Sander, D., Cai, W., Negrean, M., Buenting, C. E., Koschinsky, T., & Vlassara, H. (2007) · Diabetes Care · doi:10.2337/dc07-0320 · Cited by 159
Zimmet, P., & Alberti, K. (1997) · The Lancet · doi:10.1016/s0140-6736(97)90020-9 · Cited by 156
Farjo, K. M., Farjo, R. A., Halsey, S., Moiseyev, G. P., & Ma, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00820-12 · Cited by 157
“Type 2 diabetes is classically thought of as a metabolic disease, but it is also associated with a 2- to 4-foldincreased risk of cardiovascular disease (7, 15, 36, 37).”
BackgroundImpact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality
Eberly, L. E., Cohen, J. D., Prineas, R. J., & Yang, L. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.848 · Cited by 145
Metadata
- Authors
- Kannel, W. B., & McGee, D. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1979-03-01
- Volume
- 2
- Issue
- 2
- Pages
- 120-126
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2059537042
- Cited by
- 1,203
- References
- 0
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 40 · 2020: 31 · 2019: 39 · 2018: 41 · 2017: 38 · 2016: 43 · 2015: 55 · 2014: 50 · 2013: 35 · 2012: 36
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, impaired glucose tolerance, cardiovascular risk, coronary artery disease, peripheral vascular disease, stroke, cardiovascular mortality, heart failure, sex differences, cardiovascular risk factors, Framingham cohort
- MeSH terms
- Age Factors, Aged, Cardiovascular Diseases, Female, Glucose Tolerance Test, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk, Sex Factors, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
